|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"kuo yh"
Showing items 6-30 of 116 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-03-28 |
Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma
|
Kuo, YH;Ong, KH;Sun, DP;Tian, YF;Chou, CL;Chan, TC;Hsing, CH;Li, WS;Li, CF;Shiue, YL |
| 國家衛生研究院 |
2024-11 |
DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration
|
Lin, SY;Chang, YC;Tien, YW;Kuo, YH;Chang, HF;Ou, LC;Chen, YP;Chang, KH;Hsu, YT;Huang, YC;Yang, CM;Law, PY;Xi, JH;Tao, PL;Loh, HH;Yeh, TK;Zhuang, H;Hsieh, HP;Shih, C;Chen, CT;Yeh, SH;Ueng, SH |
| 國家衛生研究院 |
2024-07-17 |
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia
|
Huang, YH;Lin, SY;Ou, LC;Huang, WC;Chao, PK;Chang, YC;Chang, HF;Lee, PT;Yeh, TK;Kuo, YH;Tien, YW;Xi, JH;Tao, PL;Chen, PY;Chuang, JY;Shih, C;Chen, CT;Tung, CW;Loh, HH;Ueng, SH;Yeh, SH |
| 國家衛生研究院 |
2023-12-15 |
Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
|
Ong, KH;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Chan, TC;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-10-30 |
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
|
Ong, KH;Hsieh, YY;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Wu, HC;Chan, TC;Tsai, HH;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-10-14 |
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
|
Ong, KH;Hsieh, YY;Lai, HY;Sun, DP;Chen, TJ;Huang, SKH;Tian, YF;Chou, CL;Shiue, YL;Wu, HC;Chan, TC;Tsai, HH;Li, CF;Su, PA;Kuo, YH |
| 國家衛生研究院 |
2023-06-28 |
Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
|
Liang, PI;Lai, HY;Chan, TC;Li, WM;Hsing, CH;Huang, SK;Hsieh, KL;Tseng, WH;Chen, TJ;Li, WS;Chen, HD;Kuo, YH;Li, CF |
| 國家衛生研究院 |
2023-04-19 |
Prognostic significance of DNA topoisomerase II Alpha (TOP2A) in cholangiocarcinoma
|
Ong, KH;Lai, HY;Sun, DP;Chen, TJ;Huang, SK;Tian, YF;Chou, CL;Shiue, YL;Chan, TC;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2023-03-28 |
Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors
|
Chang, CI;Hsieh, CC;Wein, YS;Kuo, CC;Chang, CY;Lung, J;Cherng, JY;Chu, PC;Chang, JY;Kuo, YH |
| 國家衛生研究院 |
2023-03-27 |
Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
|
Lin, YT;Li, CF;Wu, HC;Jan, YH;Kuo, YH |
| 國家衛生研究院 |
2023-02-25 |
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
|
He, HL;Lai, HY;Chan, TC;Hsing, CH;Huang, SK;Hsieh, KL;Chen, TJ;Li, WS;Kuo, YH;Shiue, YL;Li, CF |
| 國家衛生研究院 |
2022-11 |
High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT
|
Chen, HP;Chen, CI;Liu, KW;Chen, TJ;Tian, YF;Kuo, YH;Li, WS;Tsai, HH;Wu, LC;Yeh, CF;Li, CF;Chou, CL;Lai, HY |
| 國家衛生研究院 |
2022-10-11 |
Upregulated ubiquitin D is a favorable prognostic indicator for rectal cancer patients undergoing preoperative concurrent chemoradiotherapy
|
Chou, CL;Chen, TJ;Li, WS;Lee, SW;Yang, CC;Tian, YF;Lin, CY;He, HL;Wu, HC;Shiue, YL;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2022-09 |
High MT2A expression predicts worse prognosis in patients with urothelial carcinoma
|
Li, WM;Ke, HL;Kuo, YH;Lai, HY;Chan, TC;Hsing, CH;Hsieh, KL;Li, WS;Chen, TJ;Wei, YC;Wu, WJ;Huang, SK;Li, CF |
| 國家衛生研究院 |
2022-06-30 |
Upregulation of cartilage oligomeric matrix protein predicts poor prognosis in urothelial carcinoma
|
Kuo, YH;Lai, HY;Chan, TC;Hsing, CH;Huang, SK;Hsieh, KL;Chen, TJ;Li, WS;Lu, JC;Li, CF |
| 國家衛生研究院 |
2022-03-16 |
High stromal SFRP2 expression in urothelial carcinoma confers an unfavorable prognosis
|
Lai, HY;Chiu, CC;Kuo, YH;Tsai, HH;Wu, LC;Tseng, WH;Liu, CL;Hsing, CH;Huang, SK;Li, CF |
| 國家衛生研究院 |
2022-02-11 |
Angiogenesis driven by the CEBPD–hsa-miR-429–VEGFA signaling axis promotes urothelial carcinoma progression
|
Chan, TC;Hsing, CH;Shiue, YL;Huang, SK;Hsieh, KL;Kuo, YH;Li, CF |
| 國家衛生研究院 |
2021-11-10 |
Complete and durable response to nivolumab in recurrent poorly differentiated pancreatic neuroendocrine carcinoma with high tumor mutational burden
|
Kang, NW;Tan, KT;Li, CF;Kuo, YH |
| 國家衛生研究院 |
2021-09-23 |
Secondary metabolites with anti-inflammatory activities from one actinobacteria amycolatopsis Taiwanensis
|
Su, YS;Wu, MD;Chen, JJ;Cheng, MJ;Kuo, YH;Chai, CY;Kwan, AL |
| 國家衛生研究院 |
2021-09-14 |
Two new chromones and a new coumarin from the fruit of Cnidium monnieri (L.) Cusson
|
Huang, HC;Lin, CH;Kuo, CC;Wu, MD;Cheng, MJ;Chen, JJ;Chao, CY;Huang, GJ;Kuo, YH |
| 國家衛生研究院 |
2021-09-13 |
Overexpression of pyruvate dehydrogenase kinase-3 predicts poor prognosis in urothelial carcinoma
|
Kuo, YH;Chan, TC;Lai, HY;Chen, TJ;Wu, LC;Hsing, CH;Li, CF |
| 國家衛生研究院 |
2021-08-13 |
Saccharpiscinols A–C: Flavans with potential inflammatory activities from one actinobacteria Saccharomonospora piscinae
|
Su, YS;Chen, JJ;Cheng, MJ;Chai, CY;Kwan, AL;Huang, JC;Kuo, YH |
| 國家衛生研究院 |
2021-06-17 |
Ergosta-7, 9 (11), 22-trien-3Beta-ol interferes with lps docking to lbp, cd14, and tlr4/md-2 co-receptors to attenuate the nf-kappab inflammatory pathway in vitro and drosophila
|
Hsieh, WT;Hsu, MH;Lin, WJ;Xiao, YC;Lyu, PC;Liu, YC;Lin, WY;Kuo, YH;Chung, JG |
| 中山醫學大學 |
2021 |
Association between Traditional Chinese medicine and a lower risk of dementia in patients with major depression: A case-control study
|
Lin, SK; Wang, PH; Huang, CH; Kuo, YH; Lai, JN; Wei, JCC |
| 中山醫學大學 |
2021 |
Ergosta-7,9(11),22-trien-3 beta-ol Alleviates Intracerebral Hemorrhage-Induced Brain Injury and BV-2 Microglial Activation
|
Hsueh, PJ; Wang, MH; Hsiao, CJ; Chen, CK; Lin, FL; Huang, SH; Yen, JL; Tsai, PH; Kuo, YH; Hsiao, G |
Showing items 6-30 of 116 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
|
